Alvarez & Marsal recently hosted an engaging and practical session tailored for tax, finance, and trade professionals in the pharmaceutical industry. This first edition of our Thailand Tax Talk: Industry Series explored how tax leaders in the pharma sector can respond to increasing regulatory pressure, operational complexity, and cross-border trade disruption.
Download the Presentation
Explore transfer pricing challenges in the pharmaceutical sector, shaped by high profitability, R&D investments, patent protections, and marketing intangibles.
Supreme Court clarifies the Scope of Deduction of Head Office Expenditure for Non-Residents as enshrined under section 44C of the Income Tax Act, 1961
December 26, 2025
The Supreme Court of India (SC) has pronounced a landmark judgment (the Ruling) in the case of American Express Limited and Oman International Bank (the Taxpayers), which will have a significant impact on non-residents operating in India through a branch structure.
Vietnam Tax Update: CAPITAL TRANSFER TAX FOR FOREIGN CORPORATE SELLERS UNDER NEW DECREE NO. 320/2025/ND-CP DATED 15 DECEMBER 2025
December 24, 2025
New Decree sets a 2% Capital Transfer Tax on gross proceeds for foreign sellers, outlines exclusions, and leaves open issues on taxing point.
Malaysia Widens Capital Gains Tax “Disposal” Definition: Impact on M&A, Corporate Restructuring and Exit Planning
December 18, 2025
Malaysia redefines Capital Gains Tax 'disposal' to include share ownership cessation, affecting M&A, restructuring, and exit planning. Effective Jan 1, 2026.
Key Tax Impact of Possible Revisions to the India-France Tax Treaty From a Foreign Portfolio Investor Perspective
December 17, 2025
Indian and French governments are in the closing stages of finalizing the revised Double Taxation Avoidance Agreement (DTAA or Tax Treaty).
